ArticleFrontiers in medicine2026
Primary splenic diffuse large B-cell lymphoma masquerading as systemic lupus erythematosus: a case report.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma, whereas primary splenic DLBCL (PS-DLBCL) is exceedingly rare. Lymphomas that mimic systemic lupus erythematosus (SLE) are clinically heterogeneous and share overlapping manifestations with SLE, rendering diagnosis extremely challenging. Case presentation: We report a case of an elderly patient presenting with recurrent fever, a hyperinflammatory state, and cytopenias, along with positivity for multiple autoimmune antibodies and lupus anticoagulant, which strongly suggested a clinical diagnosis of SLE. However, the patient showed no response to adequate doses of glucocorticoid therapy. Subsequent bone marrow and peripheral blood flow cytometry revealed a minor population of aberrant phenotype B cells, and positron emission tomography-computed tomography demonstrated mild splenomegaly with diffuse increased fluorodeoxyglucose uptake in the splenic parenchyma. A definitive diagnosis of PS-DLBCL was established following splenectomy. Unfortunately, the patient suffered sudden cardiac death shortly after diagnosis. Conclusion: This case highlights that PS-DLBCL can present with lupus-like manifestations as an atypical clinical feature, and such variant presentation may herald a poor prognosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.